Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05991219
Status:
RECRUITING
Last Update Posted:
2023-08-15
First Post:
2023-08-06
Brief Title:
Screening and Secondary Prevention Rheumatic Heart Disease Study
Sponsor:
National Institute of Cardiovascular Diseases Pakistan
Organization:
National Institute of Cardiovascular Diseases Pakistan
Study Overview
Official Title:
Screening and Secondary Prevention Rheumatic Heart Disease
Status:
RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
S2-RHD
Brief Summary:
After basic clinical screening including history and physical Point of care ultrasound will be performed to look at Mitral Aortic and Tricuspid Valves for regurgitation or stenosis For patients with confirmed Rheumatic heart disease RHD treatment and referral depending on stage of disease Antibiotic prescription could be shifted to community health workers delivering preventive medications via practical clinical algorithms diagnostic tools availability of appropriate antibiotics and supportive supervision Patients will have repeat imaging at 2 years and 5 years to look at the outcome of delayed progression of valve disease
Detailed Description:
Screening for RHD should be carried out since it is a major health concern that has been shown to have a treatable and detectable latent stage that can be diagnosed using a simple sensitive test point of care ultrasound and early treatment secondary prevention using antibiotic prophylaxis can provide a better outcome slow progression of disease in a cost effective way The investigators aim to study the Incidence and Prevalence of RHD in community and school settings and aim to intervene depending on the stage the disease is picked up in
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None